SciELO - Scientific Electronic Library Online

 
vol.30 issue4Present-day glaucoma surgeryUse of the Spectralis optical coherence tomography scanner to evaluate glaucoma author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Cubana de Oftalmología

On-line version ISSN 1561-3070

Abstract

FUMERO GONZALEZ, Francisco Yunier et al. New drug constellations for glaucoma. Rev Cubana Oftalmol [online]. 2017, vol.30, n.4, pp. 1-6. ISSN 1561-3070.

The present review is aimed at presenting the new therapeutic options to treat glaucoma. Medical treatment of glaucoma has undergone surprising progress as of the emergence of new hypotensive collyriums. Various firms are currently conducting research into the simplest, most effective and best tolerated therapeutic alternatives. Prostaglandin analogues are considered to be the first line therapy, but new, promising drugs are also being developed, such as latanoprostene bunod (Vesneo), netarsudil 0.02 % (Rhopressa), trabodenoson (Inotek Pharmaceuticals) and other sustained release compounds. A large number of clinical assays have been implemented and many publications have been made in the United States, the European Union and Japan which, curiously enough, have been given names of planets or constellations.

Keywords : glaucoma; drugs; clinical assays.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License